Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K, Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V, Mark, Tomer M, Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Lonial, Sagar, Dimopoulos, Meletios, Palumbo, Antonio, White, Darrell, Grosicki, Sebastian, Spicka, Ivan, Walter-Croneck, Adam, Moreau, Philippe, Mateos, Maria-Victoria, Magen, Hila, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z, Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Wu, Ka Lung, Singhal, Anil, San-Miguel, Jesus, Matsumoto, Morio, Katz, Jessica, Bleickardt, Eric, Poulart, Valerie, Anderson, Kenneth C, Richardson, Paul
Published in The New England journal of medicine (13.08.2015)
Published in The New England journal of medicine (13.08.2015)
Get full text
Journal Article
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
Avet-Loiseau, Hervé, Fonseca, Rafael, Siegel, David, Dimopoulos, Meletios A., Špička, Ivan, Masszi, Tamás, Hájek, Roman, Rosiñol, Laura, Goranova-Marinova, Vesselina, Mihaylov, Georgi, Maisnar, Vladimír, Mateos, Maria-Victoria, Wang, Michael, Niesvizky, Ruben, Oriol, Albert, Jakubowiak, Andrzej, Minarik, Jiri, Palumbo, Antonio, Bensinger, William, Kukreti, Vishal, Ben-Yehuda, Dina, Stewart, A.Keith, Obreja, Mihaela, Moreau, Philippe
Published in Blood (01.09.2016)
Published in Blood (01.09.2016)
Get full text
Journal Article
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
Dimopoulos, Meletios A, Špička, Ivan, Quach, Hang, Oriol, Albert, Hájek, Roman, Garg, Mamta, Beksac, Meral, Bringhen, Sara, Katodritou, Eirini, Chng, Wee-Joo, Leleu, Xavier, Iida, Shinsuke, Mateos, María-Victoria, Morgan, Gareth, Vorog, Alexander, Labotka, Richard, Wang, Bingxia, Palumbo, Antonio, Lonial, Sagar
Published in Journal of clinical oncology (01.12.2020)
Published in Journal of clinical oncology (01.12.2020)
Get full text
Journal Article
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Palumbo, Antonio, Hajek, Roman, Delforge, Michel, Kropff, Martin, Petrucci, Maria Teresa, Catalano, John, Gisslinger, Heinz, Wiktor-Jędrzejczak, Wiesław, Zodelava, Mamia, Weisel, Katja, Cascavilla, Nicola, Iosava, Genadi, Cavo, Michele, Kloczko, Janusz, Bladé, Joan, Beksac, Meral, Spicka, Ivan, Plesner, Torben, Radke, Joergen, Langer, Christian, Yehuda, Dina Ben, Corso, Alessandro, Herbein, Lindsay, Yu, Zhinuan, Mei, Jay, Jacques, Christian, Dimopoulos, Meletios A
Published in The New England journal of medicine (10.05.2012)
Published in The New England journal of medicine (10.05.2012)
Get full text
Journal Article
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials
Paiva, Bruno, Manrique, Irene, Dimopoulos, Meletios A., Gay, Francesca, Min, Chang-Ki, Zweegman, Sonja, Špička, Ivan, Teipel, Raphael, Mateos, María-Victoria, Giuliani, Nicola, Cavo, Michele, Hopkins, Christine Rojas, Fu, Weijun, Suryanarayan, Kaveri, Vorog, Alexander, Li, Cong, Wang, Bingxia, Estevam, Jose, Labotka, Richard, Dash, Ajeeta B.
Published in Blood (09.02.2023)
Published in Blood (09.02.2023)
Get full text
Journal Article
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M, Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K, Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C, Chanan-Khan, Asher A, Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A Kate, Schecter, Jordan M, Mateos, Maria-Victoria
Published in Haematologica (Roma) (01.12.2018)
Published in Haematologica (Roma) (01.12.2018)
Get full text
Journal Article
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study
Martin, Thomas, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Yong, Kwee, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Špička, Ivan, Baker, Ross, Kim, Kihyun, Martinez, Gracia, Min, Chang-Ki, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Koh, Youngil, Suzuki, Kenshi, Casca, France, Macé, Sandrine, Risse, Marie-Laure, Moreau, Philippe
Published in Blood cancer journal (New York) (09.05.2023)
Published in Blood cancer journal (New York) (09.05.2023)
Get full text
Journal Article
Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma
Fassmannová, Dominika, Sedlák, František, Sedláček, Jindřich, Špička, Ivan, Grantz Šašková, Klára
Published in Cancers (25.04.2020)
Published in Cancers (25.04.2020)
Get full text
Journal Article
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Mikhael, Joseph, Belhadj-Merzoug, Karim, Hulin, Cyrille, Vincent, Laure, Moreau, Philippe, Gasparetto, Cristina, Pour, Ludek, Spicka, Ivan, Vij, Ravi, Zonder, Jeffrey, Atanackovic, Djordje, Gabrail, Nashat, Martin, Thomas G., Perrot, Aurore, Bensfia, Samira, Weng, Qilong, Brillac, Claire, Semiond, Dorothée, Macé, Sandrine, Corzo, Kathryn P., Leleu, Xavier
Published in Blood cancer journal (New York) (12.05.2021)
Published in Blood cancer journal (New York) (12.05.2021)
Get full text
Journal Article
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease
Jelinek, Tomas, Sevcikova, Tereza, Zihala, David, Popkova, Tereza, Kapustova, Veronika, Broskevicova, Lucie, Capkova, Lenka, Rihova, Lucie, Bezdekova, Renata, Sevcikova, Sabina, Zidlik, Vladimir, Havel, Martin, Plonkova, Hana, Jungova, Alexandra, Minarik, Jiri, Stork, Martin, Pour, Ludek, Pavlicek, Petr, Spicka, Ivan, Maisnar, Vladimir, Radocha, Jakub, Simicek, Michal, Hajek, Roman
Published in Leukemia (01.01.2022)
Published in Leukemia (01.01.2022)
Get full text
Journal Article
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, Jesús F, Schlag, Rudolf, Khuageva, Nuriet K, Dimopoulos, Meletios A, Shpilberg, Ofer, Kropff, Martin, Spicka, Ivan, Petrucci, Maria T, Palumbo, Antonio, Samoilova, Olga S, Dmoszynska, Anna, Abdulkadyrov, Kudrat M, Schots, Rik, Jiang, Bin, Mateos, Maria-Victoria, Anderson, Kenneth C, Esseltine, Dixie L, Liu, Kevin, Cakana, Andrew, van de Velde, Helgi, Richardson, Paul G
Published in The New England journal of medicine (28.08.2008)
Published in The New England journal of medicine (28.08.2008)
Get full text
Journal Article
Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA
Martin, Tom, Richardson, Paul G, Facon, Thierry, Moreau, Philippe, Perrot, Aurore, Spicka, Ivan, Bisht, Kamlesh, Inchauspé, Marlene, Casca, France, Macé, Sandrine, Van de Velde, Helgi, Suzuki, Kenshi
Published in Haematologica (Roma) (01.10.2022)
Published in Haematologica (Roma) (01.10.2022)
Get full text
Journal Article
Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse
Klimova, Aneta, Heissigerova, Jarmila, Rihova, Eva, Brichova, Michaela, Pytlik, Robert, Spicka, Ivan, Mrazova, Katerina, Karolova, Jana, Svozilkova, Petra
Published in British journal of ophthalmology (01.11.2018)
Published in British journal of ophthalmology (01.11.2018)
Get full text
Journal Article
Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
San Miguel, Jesús F, Schlag, Rudolf, Khuageva, Nuriet K, Dimopoulos, Meletios A, Shpilberg, Ofer, Kropff, Martin, Spicka, Ivan, Petrucci, Maria Teresa, Palumbo, Antonio, Samoilova, Olga S, Dmoszynska, Anna, Abdulkadyrov, Kudrat M, Delforge, Michel, Jiang, Bin, Mateos, Maria-Victoria, Anderson, Kenneth C, Esseltine, Dixie-Lee, Liu, Kevin, Deraedt, William, Cakana, Andrew, van de Velde, Helgi, Richardson, Paul G
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
Stewart, A Keith, Dimopoulos, Meletios A, Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David S, Niesvizky, Ruben, Jakubowiak, Andrzej J, San-Miguel, Jesus F, Ludwig, Heinz, Buchanan, Jacqui, Cocks, Kim, Yang, Xinqun, Xing, Biao, Zojwalla, Naseem, Tonda, Margaret, Moreau, Philippe, Palumbo, Antonio
Published in Journal of clinical oncology (10.11.2016)
Published in Journal of clinical oncology (10.11.2016)
Get full text
Journal Article
Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
MATEOS, Maria-Victoria, RICHARDSON, Paul G, SAMOILOVA, Olga S, DMOSZYNSKA, Anna, ABDULKADYROV, Kudrat M, SCHOTS, Rik, BIN JIANG, ESSELTINE, Dixie L, LIU, Kevin, CAKANA, Andrew, VAN DE VELDE, Helgi, SAN MIGUEL, Jesús F, SCHLAG, Rudolf, KHUAGEVA, Nuriet K, DIMOPOULOS, Meletios A, SHPILBERG, Ofer, KROPFF, Martin, SPICKA, Ivan, PETRUCCI, Maria T, PALUMBO, Antonio
Published in Journal of clinical oncology (01.05.2010)
Published in Journal of clinical oncology (01.05.2010)
Get full text
Journal Article
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Orlowski, Robert Z, Nagler, Arnon, Sonneveld, Pieter, Bladé, Joan, Hajek, Roman, Spencer, Andrew, San Miguel, Jesús, Robak, Tadeusz, Dmoszynska, Anna, Horvath, Noemi, Spicka, Ivan, Sutherland, Heather J, Suvorov, Alexander N, Zhuang, Sen H, Parekh, Trilok, Xiu, Liang, Yuan, Zhilong, Rackoff, Wayne, Harousseau, Jean-Luc
Published in Journal of clinical oncology (01.09.2007)
Published in Journal of clinical oncology (01.09.2007)
Get full text
Journal Article
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study
Dimopoulos, Meletios A., Stewart, A. Keith, Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David, Mihaylov, Georgi G., Goranova‐Marinova, Vesselina, Rajnics, Péter, Suvorov, Aleksandr, Niesvizky, Ruben, Jakubowiak, Andrzej, San‐Miguel, Jesus, Ludwig, Heinz, Palumbo, Antonio, Obreja, Mihaela, Aggarwal, Sanjay, Moreau, Philippe
Published in British journal of haematology (01.05.2017)
Published in British journal of haematology (01.05.2017)
Get full text
Journal Article
A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
Orlowski, Robert Z., Gercheva, Liana, Williams, Cathy, Sutherland, Heather, Robak, Tadeusz, Masszi, Tamás, Goranova‐Marinova, Vesselina, Dimopoulos, Meletios A., Cavenagh, James D., Špička, Ivan, Maiolino, Angelo, Suvorov, Alexander, Bladé, Joan, Samoylova, Olga, Puchalski, Thomas A., Reddy, Manjula, Bandekar, Rajesh, van de Velde, Helgi, Xie, Hong, Rossi, Jean‐Franςois
Published in American journal of hematology (01.01.2015)
Published in American journal of hematology (01.01.2015)
Get full text
Journal Article